Peripheral artery disease trials in Mexico

2 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Taking people
  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  Where

  Mexico City, Monterrey

  Age

  18 years and over

  People

  3,110 worldwide

  Run by

  CSL Behring

  See details and how to joinNCT05485961 · EU 2022-500273-14-00
• No phaseNot yet taking people in Mexico
  Effectiveness of an Inpatient Rehabilitation and Prosthetic Training Model in Patients With Vascular and Metabolic Transfemoral Amputation

  Where

  Mexico City

  Age

  18 years and over

  People

  54

  Run by

  Instituto Nacional de Rehabilitacion

  See details and how to joinNCT07665775